These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4552442)

  • 21. Mycobacterium mucogenicum group infections: a review.
    Adékambi T
    Clin Microbiol Infect; 2009 Oct; 15(10):911-8. PubMed ID: 19845703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multifocal osteomyelitis caused by Mycobacterium chelonei. A therapeutic dilemma.
    Hing DC; Delohery JF; Abbott MR
    Med J Aust; 1983 May; 1(11):529-31. PubMed ID: 6843447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo antimycobacterial activity of antiinflammatory drug, diclofenac sodium.
    Dutta NK; Kumar KA; Mazumdar K; Dastidar SG
    Indian J Exp Biol; 2004 Sep; 42(9):922-7. PubMed ID: 15462188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mycobacterial bases of the therapy of mycobacterioses].
    Hejný J
    Z Erkr Atmungsorgane; 1982; 158(1-2):163-7. PubMed ID: 7072265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preclinical study of therapeutic agents used against Mycobacterium avium complex infections--with special reference to new macrolides and new quinolones].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1996 Sep; 71(9):531-5. PubMed ID: 8999135
    [No Abstract]   [Full Text] [Related]  

  • 26. Pulmonary infection with Mycobacterium chelonei: successful treatment with one drug based on disk diffusion susceptibility data.
    Irwin RS; Pratter MR; Corwin RW; Farrugia R; Teplitz C
    J Infect Dis; 1982 May; 145(5):772. PubMed ID: 7077102
    [No Abstract]   [Full Text] [Related]  

  • 27. The relationship between the in vitro drug susceptibility of opportunist mycobacteria and their in vivo response to treatment.
    Heginbothom ML
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):539-45. PubMed ID: 11409581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mode of action of antimycobacterial drugs.
    David HL; Laszlo A; Rastogi N
    Acta Leprol; 1989; 7 Suppl 1():189-94. PubMed ID: 2503988
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on atypical mycobacteria. 8. Chemotherapy and auto-senitized vaccine therapy aganist experimentally atypical mycobacteriosis of mice--experiments on Moristrain infection in mice.
    Ogawa T; Hiramatsu S
    Kitasato Arch Exp Med; 1969 Dec; 42(3):69-81. PubMed ID: 5400760
    [No Abstract]   [Full Text] [Related]  

  • 30. [Statistical observation on chronological development of sensitivity of various bacteria to antibiotics: acid fast bacteria (1959-1971)].
    Shimohama Y; Fukazawa S; Ogi K; Shimogaki F; Uete T
    Nihon Rinsho; 1973 Jun; 31(6):2146-50. PubMed ID: 4738454
    [No Abstract]   [Full Text] [Related]  

  • 31. [Atypical mycobacterium infections].
    Keller H
    Schweiz Med Wochenschr; 1972 Jul; 102(27):949-53. PubMed ID: 5049301
    [No Abstract]   [Full Text] [Related]  

  • 32. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 33. Mycobacterium simiae Infection in an Immunocompromised Patient without Acquired Immunodeficiency Syndrome.
    Braun-Saro B; Esteban J; Jiménez S; Castrillo JM; Fernández-Guerrero ML
    Clin Infect Dis; 2002 Mar; 34(5):E26-7. PubMed ID: 11810603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycobacterium fortuitum osteomyelitis of the calcaneus secondary to a puncture wound.
    Chang MJ; Barton LL
    J Pediatr; 1974 Oct; 85(4):517-9. PubMed ID: 4155437
    [No Abstract]   [Full Text] [Related]  

  • 35. Antimycobacterial activity of some pyrido-1,2-thiazine derivatives.
    Malinka W; Redzicka A; Swiatek P
    Acta Pol Pharm; 2002; 59(6):439-42. PubMed ID: 12669767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of mycobacterial infections.
    Barrow WW
    Rev Sci Tech; 2001 Apr; 20(1):55-70. PubMed ID: 11288520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimycobacterial activity of new quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives.
    Ortega MA; Montoya ME; Jaso A; Zarranz B; Tirapu I; Aldana I; Monge A
    Pharmazie; 2001 Mar; 56(3):205-7. PubMed ID: 11265583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on atypical mycobacteria. X. Experimental approach to the etiology of atypical mycobacteriosis.
    Ogawa T; Motomura K
    Kekkaku; 1971 Sep; 46(9):365-70. PubMed ID: 5122006
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical and bacteriological comparisons in patients excreting atypical mycobacteria].
    Moisescu V; Fanea E; Popescu M; Petrescu G; Cornea G; Cordea I; Florescu S; Vaida T
    Ftiziologia; 1971; 20(3):249-57. PubMed ID: 4950549
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antituberculous action of a new antibiotic, Lividomycin. Effect on experimental tuberculosis of mice and cross resistance with other antituberculous agents].
    Tsukamura M; Mizuno S; Yamamoto M
    Kekkaku; 1970 Aug; 45(8):263-72. PubMed ID: 4989999
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.